Breaking News Instant updates and real-time market news.

WYNN

Wynn Resorts

$160.13

3.27 (2.08%)

08:12
07/10/18
07/10
08:12
07/10/18
08:12

Technical Take: Wynn Resorts rises for third session, analyst action

The stock was last up over 1.4% to $162.50 in pre-market trading. At that price next resistance is at $165.52. Support is at $160.42. As previously reported, Stifel upgraded the shares to Buy, but pared its price target from $209 down to $207.

WYNN Wynn Resorts
$160.13

3.27 (2.08%)

07/10/18
STFL
07/10/18
UPGRADE
Target $207
STFL
Buy
Wynn Resorts upgraded to Buy from Hold at Stifel
Stifel analyst Steven Wieczynski upgraded Wynn Resorts to Buy from Hold, as he believes the pullback in the stock recently has created a compelling opportunity. While acknowledging his upgrade "might be a bit early" given difficult VIP comparisons through July, Wieczynski argues that tougher VIP comparisons are now baked into expectations and he would rather be early than late "given the volatility of swings in Macau related stocks." His long-term case to own Wynn shares is built on expectations for continued Macau share gains, a ramp in free cash flow in 2019, and the potential for margin expansion, the analyst tells investors. Wieczynski also trimmed his price target on Wynn shares to $207 from $209.
07/05/18
MSCO
07/05/18
NO CHANGE
MSCO
Pullback in Macau gaming names a buying opportunity, says Morgan Stanley
Morgan Stanley analyst Thomas Allen believes the recent selloff in Macau gaming stocks is overdone, as he contends the fact that Macau's gaming revenue growth has missed on the headline for two months in a row is attributable to rising expectations, foreign exchange impacts and likely an improper factoring in of seasonality and the World Cup. Q2 gross gaming revenue growth of 17.2% still beat his forecast of 16%, noted Allen, who said Las Vegas Sands (LVS) continues to be his favored gaming name. He also has an Overweight rating on MGM Resorts (MGM). Allen keeps an Equal Weight rating on Wynn Resorts (WYNN), but sees the stock becoming increasingly attractive if Macau is still "very healthy," as he suspects.
06/29/18
JEFF
06/29/18
NO CHANGE
Target $229
JEFF
Buy
Wynn Resorts long-term value remains intact, says Jefferies
Jefferies analyst David Katz revisited his channel checks and management's public commentary with shares of Wynn Resorts down 16% month-to-date. While near-term expectations may be high, long-term value remains intact, Katz tells investors in a research note titled "A Multitude of Ways to Wynn." He continues to believe that Wynn's current portfolio and completion of Boston will result in a "profound capital pivot" by 2019. The analyst trimmed his price target for the shares to $229 and $230 and reiterates a Buy rating on the name.
06/04/18
DBAB
06/04/18
NO CHANGE
Target $215
DBAB
Buy
Wynn Resorts price target lowered to $215 from $219 at Deutsche Bank
Deutsche Bank analyst Carlo Santarelli lowered his price target for Wynn Resorts to $215 citing "slightly softer" than previously anticipated higher end trends Q2 to date in the Macau market. Checks indicate the proximity of this year's World Cup in Russia, relative to the 2014 event in Brazil, could cause some VIP softness in June as junkets arrange trips for players, Santarelli tells investors in a research note. He remains bullish on Wynn's long-term story and keeps a Buy rating on the shares.

TODAY'S FREE FLY STORIES

SIEGY

Siemens

$0.00

(0.00%)

09:00
10/22/18
10/22
09:00
10/22/18
09:00
Periodicals
Siemens CEO won't attend Saudi investment conference, Reuters reports »

Joe Kaeser, the CEO of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CRBP

Corbus Pharmaceuticals

$7.26

-0.54 (-6.92%)

08:59
10/22/18
10/22
08:59
10/22/18
08:59
Conference/Events
Corbus Pharmaceuticals management to meet with RBC Capital »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

SNAP

Snap

$6.82

0.01 (0.15%)

08:59
10/22/18
10/22
08:59
10/22/18
08:59
Recommendations
Snap analyst commentary  »

Snap price target lowered…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Oct

  • 07

    Nov

BSX

Boston Scientific

$36.53

-0.99 (-2.64%)

08:58
10/22/18
10/22
08:58
10/22/18
08:58
Recommendations
Boston Scientific analyst commentary  »

Boston Scientific price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

SVU

Supervalu

$32.50

0.01 (0.03%)

08:58
10/22/18
10/22
08:58
10/22/18
08:58
Hot Stocks
Breaking Hot Stocks news story on Supervalu »

Supervalu trading halted,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UROV

Urovant Sciences

$11.62

-0.63 (-5.14%)

08:58
10/22/18
10/22
08:58
10/22/18
08:58
Initiation
Urovant Sciences initiated  »

Urovant Sciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

STRO

Sutro Biopharma

$14.55

0.03 (0.21%)

08:57
10/22/18
10/22
08:57
10/22/18
08:57
Initiation
Sutro Biopharma initiated  »

Sutro Biopharma initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SLB

Schlumberger

$58.49

0.06 (0.10%)

08:56
10/22/18
10/22
08:56
10/22/18
08:56
Recommendations
Schlumberger analyst commentary  »

Schlumberger price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BXS

BancorpSouth

$28.47

-0.72 (-2.47%)

08:55
10/22/18
10/22
08:55
10/22/18
08:55
Recommendations
BancorpSouth analyst commentary  »

BancorpSouth price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BXS

BancorpSouth

$28.47

-0.72 (-2.47%)

08:55
10/22/18
10/22
08:55
10/22/18
08:55
Recommendations
BancorpSouth analyst commentary  »

BancorpSouth price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$219.28

3.3 (1.53%)

, AMD

AMD

$23.66

-2.95 (-11.09%)

08:55
10/22/18
10/22
08:55
10/22/18
08:55
Options
Notable open interest changes for October 22nd »

Friday's total…

AAPL

Apple

$219.28

3.3 (1.53%)

AMD

AMD

$23.66

-2.95 (-11.09%)

PBR

Petrobras

$15.49

0.16 (1.04%)

MU

Micron

$40.44

-0.86 (-2.08%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 06

    Dec

SVMK

SurveyMonkey

$12.97

-0.78 (-5.67%)

08:53
10/22/18
10/22
08:53
10/22/18
08:53
Initiation
SurveyMonkey initiated  »

SurveyMonkey initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ORCL

Oracle

$47.59

0.19 (0.40%)

08:52
10/22/18
10/22
08:52
10/22/18
08:52
Conference/Events
Oracle to host investor meeting »

Financial Investor…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 22

    Oct

  • 24

    Oct

  • 25

    Oct

  • 25

    Oct

  • 14

    Nov

EBAY

eBay

$28.73

-2.83 (-8.97%)

08:51
10/22/18
10/22
08:51
10/22/18
08:51
Technical Analysis
Technical Take: eBay falls, analyst downgrades »

The stock was last down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Oct

  • 03

    Mar

ABBV

AbbVie

$88.01

-1.93 (-2.15%)

08:51
10/22/18
10/22
08:51
10/22/18
08:51
Recommendations
AbbVie analyst commentary  »

AbbVie price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Nov

PYPL

PayPal

$84.75

7.25 (9.35%)

08:50
10/22/18
10/22
08:50
10/22/18
08:50
Periodicals
PayPal CFO tells Yahoo Finance no plans to spin off Venmo »

PayPal CFO John Rainey…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 13

    Nov

  • 13

    Nov

  • 26

    Nov

IONS

Ionis Pharmaceuticals

$45.21

-1.13 (-2.44%)

, AZN

AstraZeneca

$39.21

0.25 (0.64%)

08:50
10/22/18
10/22
08:50
10/22/18
08:50
Hot Stocks
Ionis Pharmaceuticals presents Phase 1b/2 data of danvatirsen »

Ionis Pharmaceuticals…

IONS

Ionis Pharmaceuticals

$45.21

-1.13 (-2.44%)

AZN

AstraZeneca

$39.21

0.25 (0.64%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 07

    Nov

  • 27

    Nov

AEE

Ameren

$66.06

1.16 (1.79%)

08:49
10/22/18
10/22
08:49
10/22/18
08:49
Hot Stocks
Ameren Missouri to acquire 157-megawatt wind facility in northwest Missouri »

Ameren Missouri, a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Oct

  • 11

    Nov

SALT

Scorpio Bulkers

$6.32

0.07 (1.12%)

08:47
10/22/18
10/22
08:47
10/22/18
08:47
Earnings
Scorpio Bulkers reports Q3 EPS (1c), consensus 3c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

AAPL

Apple

$219.28

3.3 (1.53%)

08:47
10/22/18
10/22
08:47
10/22/18
08:47
Recommendations
Apple analyst commentary  »

Apple' advertising…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MU

Micron

$40.44

-0.86 (-2.08%)

08:46
10/22/18
10/22
08:46
10/22/18
08:46
Initiation
Micron initiated  »

Micron initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SJI

South Jersey Industries

$35.20

0.15 (0.43%)

08:46
10/22/18
10/22
08:46
10/22/18
08:46
Conference/Events
South Jersey Industries to host investor meeting »

Investor meeting to be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DTEA

DavidsTea

$2.60

-0.11 (-4.06%)

, CRMD

CorMedix

$1.24

-0.37 (-22.98%)

08:45
10/22/18
10/22
08:45
10/22/18
08:45
Options
Largest borrow rate increases among liquid names »

Latest data shows the…

DTEA

DavidsTea

$2.60

-0.11 (-4.06%)

CRMD

CorMedix

$1.24

-0.37 (-22.98%)

NBEV

New Age Beverages

$5.83

-0.73 (-11.13%)

CWH

Camping World

$21.37

0.52 (2.49%)

EWJ

iShares MSCI Japan Index Fund

$56.64

0.08 (0.14%)

NEPT

Neptune Wellness

$4.06

-0.26 (-6.02%)

QID

ProShares UltraShort QQQ

$40.24

0.13 (0.32%)

BZUN

Baozun

$39.66

0.21 (0.53%)

IQ

iQIYI

$23.56

-0.9 (-3.68%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JTPY

JetPay

$2.07

(0.00%)

08:45
10/22/18
10/22
08:45
10/22/18
08:45
Hot Stocks
Breaking Hot Stocks news story on JetPay 

JetPay trading resumes

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GWRS

Global Water Resources

$10.67

0.17 (1.62%)

08:44
10/22/18
10/22
08:44
10/22/18
08:44
Hot Stocks
Global Water Resources receives extension on taxable gain »

Global Water Resources…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.